According to IMARC Group’s latest report, titled “Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global next-generation sequencing (NGS) market size reached US$ 13.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 40.25 Billion by 2027, exhibiting at a CAGR of 19.5% during 2022-2027.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/next-generation-sequencing-market/requestsample
Next-generation sequencing (NGS) refers to a deoxyribonucleic acid (DNA) sequencing technique that helps in genetic research. It involves single-molecule real-time (SMRT), nanopore, ion semiconductor, and sequencing by synthesis (SBS) as standard methodologies. NGS provides improved scalability, prepares a sample for subsequent reactions, interprets sequenced data and genes associated with the clinical conditions, and offers small sample inputs with higher precision. Consequently, NGS finds extensive applications in genetic therapies, re-sequencing targets, non-coding ribonucleic acid (RNA) expression profiling, and biological drug discovery.
Next-Generation Sequencing (NGS) Market Trends:
The rising need for effective medications to treat various chronic diseases, including cancer, tuberculosis, and meningococcal, which is experiencing a significant prevalence amongst the geriatric population, is primarily driving the market. Moreover, escalating investments by governments in pharmaceutical companies and genome mapping projects to understand the link between genetics and diseases is aiding the market growth. Furthermore, the fueling utilization of automated benchtop solutions, test kits, and testing services for non-invasive pre-natal assessments, cancer diagnosis, and genetic tests is contributing to the market growth. Additionally, continuous technological innovations in NGS instruments and sequencers, coupled with their wide-scale adoption due to their lower price and high efficiency, are propelling the market growth. Besides this, substantial improvements in the healthcare infrastructure and the advent of cloud-based NGS devices to perform DNA synthesis are contributing to the market growth. Apart from this, rising collaborative research and development (R&D) activities to engineer personalized medicines and discover new biomarkers to detect diseases are propelling the market growth.
Next-Generation Sequencing (NGS) Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the next-generation sequencing market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Agilent Technologies
- Becton Dickinson and Company
- 10x Genomics
- BGI Group
- Eurofins Scientific
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Genewiz, Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences
- PerkinElmer
- Thermo Fisher Scientific
- Qiagen N.V.
- GenapSys Inc.
Key Market Segmentation:
The report has segmented the global next-generation sequencing market on the basis of sequencing type, product type, technology, application, end-user and region.
Breakup by Sequencing Type:
- Whole Genome Sequencing
- Targeted Resequencing
- Whole Exome Sequencing
- RNA Sequencing
- CHIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Others
Breakup by Product Type:
- Instruments
- Reagents and Consumables
- Software and Services
Breakup by Technology:
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Others
Breakup by Application:
- Drug Discovery and Personalized Medicine
- Genetic Screening
- Diagnostics
- Agriculture and Animal Research
- Others
Breakup by End-User:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2039&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Life Science Analytics Market Report: https://bit.ly/3Ke6p6o
Drug Discovery Informatics Market Report: https://bit.ly/3pzagBH
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com